Suzhou Fengbei Biotech Stock Co (SHSE:603334) EBITDA Margin %: 4.19% (As of Mar. 2026) — 54% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603334 Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
40 GF Score
Price ¥32.07
! 4 Warning Signs
View Full Analysis

What is Suzhou Fengbei Biotech Stock Co EBITDA Margin %?

Suzhou Fengbei Biotech Stock Co SHSE:603334 +0.88% 40 EBITDA Margin % is 4.19% as of Mar. 2026, which is 54% below its 10-year median of 9.17. GuruFocus rates SHSE:603334 with a GF Score™ of 40/100. The stock has 4 warning signs investors should review. Among 236 Waste Management companies, Suzhou Fengbei Biotech Stock Co ranks worse than 66.95% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Suzhou Fengbei Biotech Stock Co's EBITDA for the three months ended in Mar. 2026 was ¥46 Mil. Suzhou Fengbei Biotech Stock Co's Revenue for the three months ended in Mar. 2026 was ¥1,109 Mil. Therefore, Suzhou Fengbei Biotech Stock Co's EBITDA margin for the quarter that ended in Mar. 2026 was 4.19%.


Suzhou Fengbei Biotech Stock Co  (SHSE:603334) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Suzhou Fengbei Biotech Stock Co EBITDA Margin % Related Terms


Suzhou Fengbei Biotech Stock Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Suzhou Fengbei Biotech Stock Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Fengbei Biotech Stock Co EBITDA Margin % Chart

Suzhou Fengbei Biotech Stock Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial 9.42 10.22 10.23 8.52 6.05

Suzhou Fengbei Biotech Stock Co Quarterly Data
Dec20 Dec21 Dec22 Dec23 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.17 6.88 4.60 3.12 4.19

SHSE:603334 vs WM, RSG, WCN: EBITDA Margin % Comparison

For the Waste Management subindustry, Suzhou Fengbei Biotech Stock Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Fengbei Biotech Stock Co EBITDA Margin % vs Waste Management Industry

For the Waste Management industry and Industrials sector, Suzhou Fengbei Biotech Stock Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Suzhou Fengbei Biotech Stock Co's EBITDA Margin % falls into.


SHSE:603334
40GF Score
Suzhou Fengbei Biotech Stock Co Ltd SHSE:603334
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Fengbei Biotech Stock Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Suzhou Fengbei Biotech Stock Co's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=191.796/3170.796
=6.05 %

Suzhou Fengbei Biotech Stock Co's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=46.479/1108.73
=4.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 4.19% mean?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a EBITDA Margin % of 4.19% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. This is 54% below median its historical median of 9.17. Over the past decade, Suzhou Fengbei Biotech Stock Co's EBITDA Margin % has ranged from 4.61 to 10.23. According to the industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #158 out of 236 companies in the Waste Management industry, placing it in the top 66.9%.
Is Suzhou Fengbei Biotech Stock Co's EBITDA Margin % too high?
Suzhou Fengbei Biotech Stock Co's current EBITDA Margin % of 4.19% is 54% below median its 10-year median of 9.17. Over the past 10 years, this metric has ranged from a low of 4.61 to a high of 10.23. The Waste Management industry median EBITDA Margin % is 12.67. Suzhou Fengbei Biotech Stock Co's value of 4.19% is 66.9% below this industry median. Based on the distribution chart, Suzhou Fengbei Biotech Stock Co ranks #158 out of 236 companies in the Waste Management industry, which is below the industry midpoint. Overall, Suzhou Fengbei Biotech Stock Co has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does Suzhou Fengbei Biotech Stock Co's EBITDA Margin % compare to WM and RSG?
According to the Waste Management industry distribution chart, Suzhou Fengbei Biotech Stock Co ranks #158 out of 236 companies for EBITDA Margin %. This places Suzhou Fengbei Biotech Stock Co in the lower half of its industry. The industry median EBITDA Margin % is 12.67. Suzhou Fengbei Biotech Stock Co's value of 4.19% is 66.9% below this benchmark. Historically, Suzhou Fengbei Biotech Stock Co's own EBITDA Margin % has ranged from 4.61 to 10.23 over the past decade. While the company's 10-year median is 9.17 vs. the industry median of 12.67, Suzhou Fengbei Biotech Stock Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Waste Management company?
The median EBITDA Margin % among Waste Management companies is 12.67, based on 236 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Suzhou Fengbei Biotech Stock Co's current EBITDA Margin % of 4.19% is 66.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Suzhou Fengbei Biotech Stock Co and its competitors. For the Waste Management industry, the median EBITDA Margin % is 12.67 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Suzhou Fengbei Biotech Stock Co's current EBITDA Margin % is 4.19%, which is 54% below median its own 10-year median of 9.17. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Fengbei Biotech Stock Co stock overvalued right now?
Suzhou Fengbei Biotech Stock Co (SHSE:603334) has a current EBITDA Margin % of 4.19%. The current EBITDA Margin % is 4.19%, which is 54% below median its 10-year median of 9.17 and 66.9% below the Waste Management industry median of 12.67. Suzhou Fengbei Biotech Stock Co's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Suzhou Fengbei Biotech Stock Co (SHSE:603334), the current EBITDA Margin % is 4.19% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Suzhou Fengbei Biotech Stock Co Business Description

Address No. 1 Donghai Road, Yangtze River International Chemical Industrial Park, Jiangsu Province, Zhangjiagang, CHN, 215600
Suzhou Fengbei Biotech Stock Co Ltd is focused on the comprehensive utilization of waste oil and fat resources. The company is engaged in the research and development, production, and sales of industrial packaging materials, methyl oleate, and methylated soybean oil (excluding food products). It operates as an independent import and export agent for various commodities and technologies. The company's licensed projects include Fertilizer production, and General projects include Technical services, technical development, technical consultation, technical exchange, technology transfer, and technology promotion. It is into the research and development of bio-organic fertilizers, compound microbial fertilizers, and bio-pesticide technology.
40GF Score

Get the complete analysis for SHSE:603334

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥32.07
Price